We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
(-3.5%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$72.5M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$54.4M |
| 3 |
Blackstone
BX
|
+$44M |
| 4 |
Airbnb
ABNB
|
+$37.4M |
| 5 |
Everest Group
EG
|
+$30.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$57.8M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$39.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$23.8M |
| 4 |
iShares Global Infrastructure ETF
IGF
|
+$19.2M |
| 5 |
PDCE
PDC Energy, Inc.
PDCE
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.73% |
| 2 | Healthcare | 12.76% |
| 3 | Financials | 12.67% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Beyond Air
XAIR
$3.86M
| $77.1K | ﹤0.01% |
83
-5
| -6% | -$6.57K |
|
3277
Veralto
VLTO
$24B
| $76.5K | ﹤0.01% |
+904
| New | +$75.3K |
|
3278
Open Text
OTEX
$6.04B
| $75.5K | ﹤0.01% |
2,150
+55
| +3% | +$2.15K |
|
|
THRX
3279
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $75.2K | ﹤0.01% |
27,958
+661
| +2% | +$2.59K |
|
3280
Transcontinental Realty Investors
TCI
$323M
| $74.6K | ﹤0.01% |
2,435
+153
| +7% | +$5.16K |
|
3281
PepGen
PEPG
$197M
| $74.4K | ﹤0.01% |
14,649
-882
| -6% | -$5.62K |
|
|
HHR
3282
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
| $74.1K | ﹤0.01% |
4,932
| – | – |
|
3283
Zura Bio
ZURA
$566M
| $73.9K | ﹤0.01% |
11,199
+3,089
| +38% | +$20.6K |
|
3284
Cenovus Energy
CVE
$52.1B
| $73.8K | ﹤0.01% |
3,547
+35
| +1% | +$668 |
|
|
LK
3285
DELISTED
Luckin Coffee Inc. American Depositary Shares
LK
| $73.6K | ﹤0.01% |
2,103
+360
| +21% | +$12.6K |
|
|
KWY
3286
Kingsway Corp
KWY
$293M
| $72.5K | ﹤0.01% |
9,603
+585
| +6% | +$4.88K |
|
3287
Cue Biopharma
CUE
$114M
| $72.2K | ﹤0.01% |
1,047
+67
| +7% | +$6.54K |
|
|
DZSI
3288
DELISTED
DZS Inc. Common Stock
DZSI
| $72.1K | ﹤0.01% |
34,358
-3,478
| -9% | -$10K |
|
3289
Biote Corp
BTMD
$44.9M
| $72.1K | ﹤0.01% |
14,080
+1,138
| +9% | +$6.71K |
|
|
DRD
3290
DRDGold
DRD
$2.05B
| $71.7K | ﹤0.01% |
8,641
| – | – |
|
|
AZUL
3291
DELISTED
Azul
AZUL
| $71.5K | ﹤0.01% |
8,325
-6,750
| -45% | -$67K |
|
3292
Pulse Biosciences
PLSE
$3.02B
| $71.5K | ﹤0.01% |
17,737
+1,952
| +12% | +$12.1K |
|
3293
SKYX Platforms
SKYX
$164M
| $71.4K | ﹤0.01% |
50,282
+5,045
| +11% | +$9.68K |
|
|
NGM
3294
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $69.4K | ﹤0.01% |
64,866
+2,811
| +5% | +$5.82K |
|
3295
BioXcel Therapeutics
BTAI
$27.8M
| $69.3K | ﹤0.01% |
1,712
-54
| -3% | -$5.46K |
|
3296
Priority Technology Holdings
PRTH
$444M
| $68.7K | ﹤0.01% |
21,204
| – | – |
|
3297
Nkarta
NKTX
$172M
| $68.6K | ﹤0.01% |
49,330
-198
| -0.4% | -$376 |
|
3298
Century Therapeutics
IPSC
$361M
| $68.4K | ﹤0.01% |
34,202
+750
| +2% | +$2K |
|
3299
HireQuest
HQI
$185M
| $68.3K | ﹤0.01% |
4,424
+314
| +8% | +$6.58K |
|
|
AKTS
3300
DELISTED
Akoustis Technologies Inc
AKTS
| $67.3K | ﹤0.01% |
89,353
-9,829
| -10% | -$18.1K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
- RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
- RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
- RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
- RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.
Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.